BridgeMD
New treatment option for Sepsis
Official title Characterization and Longitudinal Monitoring of Muscular Phenotype in Patients Admitted to Intensive Care for Sepsis
ClinicalTrials.gov ID: NCT07074028
What this study is testing
What is blood sampling?
blood sampling is an investigational medicine, being studied as a potential treatment for sepsis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Approximately 40% of patients develop muscle dysfunction during their stay in intensive care, particularly in the context of sepsis. This dysfunction represents an acquired muscle injury that is secondary to the primary illness that led to ICU admission.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participants admitted to ICU with an expected length of stay greater than 7 days.
- Expected duration of invasive mechanical ventilation greater than 48 hours.
- Diagnosis of sepsis upon ICU admission (presence of an infection and a SOFA score ≥ 2, or an increase of ≥ 2 points if organ dysfunction was present...
- Informed consent obtained from the participant or from a designated surrogate decision-maker
You likely can't join if
- Pregnant women.
- Participants not affiliated with the national health insurance system.
- Participants under legal protection (guardianship or conservatorship).
- Moribund participants (end-of-life patients).
- Participants with active cancer.
- Participants with chronic neuromuscular disorders or admitted to the ICU for an acute neuromuscular condition.
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Brieuc, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Brieuc, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.